Impaired Bone Morphogenetic Protein Receptor II Signaling in a Transforming Growth Factor-β–Dependent Mouse Model of Pulmonary Hypertension and in Systemic Sclerosis

Overview of attention for article published in American Journal of Respiratory & Critical Care Medicine, March 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter: 4 X users

patent: 8 patents

Readers on

mendeley: 61 Mendeley

So far, Altmetric has seen 8 patents that reference this research output.

GREMLIN-1 CRYSTAL STRUCTURE AND INHIBITORY ANTIBODY

Application EP-4768043-A2

European Patent Office

01 Jul 2026

Gremlin-1 crystal structure and inhibitory antibody

Grant US-12473355-B2

United States of America

18 Nov 2025

Gremlin-1 inhibitor for the treatment of a bone fracture or bone defect

Grant US-12240896-B2

United States of America

04 Mar 2025

Gremlin-1 antagonist for the prevention and treatment of cancer

Grant US-12162934-B2

United States of America

10 Dec 2024

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 4 additional patents.